KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Depreciation and Depletion (2016 - 2019)

Historic Depreciation and Depletion for Elevance Health (ELV) over the last 11 years, with Q4 2019 value amounting to $38.0 million.

  • Elevance Health's Depreciation and Depletion rose 1875.0% to $38.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was $147.0 million, marking a year-over-year increase of 1854.84%. This contributed to the annual value of $94.0 million for FY2025, which is 1047.62% down from last year.
  • As of Q4 2019, Elevance Health's Depreciation and Depletion stood at $38.0 million, which was up 1875.0% from $38.0 million recorded in Q3 2019.
  • Elevance Health's Depreciation and Depletion's 5-year high stood at $38.0 million during Q3 2019, with a 5-year trough of $25.1 million in Q1 2015.
  • In the last 5 years, Elevance Health's Depreciation and Depletion had a median value of $27.8 million in 2015 and averaged $29.6 million.
  • As far as peak fluctuations go, Elevance Health's Depreciation and Depletion tumbled by 666.67% in 2015, and later skyrocketed by 2258.06% in 2019.
  • Over the past 5 years, Elevance Health's Depreciation and Depletion (Quarter) stood at $27.8 million in 2015, then decreased by 5.4% to $26.3 million in 2016, then rose by 10.27% to $29.0 million in 2017, then grew by 10.34% to $32.0 million in 2018, then grew by 18.75% to $38.0 million in 2019.
  • Its last three reported values are $38.0 million in Q4 2019, $38.0 million for Q3 2019, and $37.0 million during Q2 2019.